California Cancer Reporting System Standards, Volume III

CS Mets at Dx-Lung

identifiers

CCR ID

NAACCR ID

E1175

2854

OWNER

AJCC

DESCRIPTION

Identifies the presence of distant metastatic involvement of the lung at time of diagnosis.The presence of metastatic lung disease at diagnosis is an independent prognostic indicator, and it is used by Collaborative Staging to derive TNM-M codes and SEER Summary Stage codes for some sites.

leveLS

Tumors, Admissions

LENGTH

1

ALLOWABLE VALUES

er1041 CS Mets at Dx-Lung (2010)

 

0, 1, 8, 9

Site specific

Blank

Year of Diagnosis is before 2010 or after 2015

 

See the most current version of the Collaborative Stage Data Collection System (http://cancerstaging.org) for rules and site-specific codes and coding structures.

SOURCE

See CS Version Derived.

uPDATE

See CS Mets at DX--Bone.

CONSOLIDATED DATA EXTRACT

Yes

INTERFIELD EDITS

IF385 CS Items, Type Reporting Source-DCO

IF846 CS Mets at DX, Rectum Schema (CS)

IF848 CS Mets at DX, Colon Schema (CS)

IF878 CS Items - SEER Required - Non-SSF (CS)

IF885 CS Mets at DX--Lung, CS Mets at DX

IF1104 CS Mets at DX-BBLL, LymphomaOcularAdnexa

IF1105 CS Mets at DX-BBLL, MycosisFungoides

INTERRECord EDITS

N/A

historical changes

2010

New data item for 2010.  CSv1 to CSv2 Conversion Specs documentation states to leave these blank (see https://cancerstaging.org/cstage/coding/Documents/csv1tocsv2conversionspecs.pdf).

 

Added IF #846, 848, and 885.

05/2016

Per NAACCR v16, CS Mets at DX-Lung is no longer required for DX Year 2016 and forward. Updated description and codes to match NAACCR. Update logic revised to follow new year requirements.